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ABSTRACT 
This work employs organic and polymer synthesis to construct a novel polymeric 
contrast agent for the application of mild traumatic brain injury in which affects so many 
lives not only in the united states by also internationally as well. Our approach to 
tackling this issue is to take advantage of diffuse axial injury and the phenomena of the 
fluctuation of free calcium ions after trauma occurs. We aim to take advantage of 
chelation chemistry. For this, we carefully construct a polymeric contrast agent that 
contains free carboxylic acid groups that can alternate between coordinating with 
gadolinium species in our contrast agent and the free calcium ions. In this way, what is 
hopefully obtained is an ion response polymeric contrast agent that can be for medical 
imaging purposes.  
The first proposed idea of our work involves simple free radical polymerization 
containing carboxylic acids on the backbone of the polymer and a conjugated chelating 
component, which is vastly like ProHance(gadoteridol) a commercially available contrast 
agent. The polymer contrast agents were then successfully characterized using nuclear 
magnetic resonance (NMR) and Fourier transform inferred spectroscopy (FTIR) for 
structural analysis. Furthermore, magnetic resonance imaging (MRI) imagining 
properties determined using a 3 T coil, and the result were recorded and analyzed. 
While in later works, a more know calcium chelator 1,2 bis(aminophenoxy)ethane-N, N, 
N′, N′-tetraacetic acid (BAPTA) is latter introduced as well as more advanced synthetic 
techniques in hopes better to improve the first design of the original concept.      
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CHAPTER ONE 
Introduction and review of literature 
 
1.1 Principals of magnetic resonance imaging  
Magnetic resonance imaging (MRI) has emerged as one of the most versatile medical 
imaging techniques, providing a pathway for non-evasive imaging techniques. In 
essence, it takes advantage of the hydrogen nucleus due to the high natural 
abundance of the H1 of 99.9844% and deuterium 0.0156% (1). MRI is a great practical 
application for fundamental principles. When water protons in the body are 
introduced to a magnetitic field, the magnetic dipole of the protons align in the 
direction of the magnetic field, as shown in figure 1.1 (2).  
 
Figure 1.1) Alignment of atomic nuclei by magnetic field then applied radio pulse (2). 
 
The radio pulse also, shown in figure 1.1, affect the equilibrium position of the 
protons, which gives rise to two different types of relaxation mechanisms, spin-lattice 
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(T1) and spin-spin relaxation(T2). T1 is the equilibration of the net magnetization from 
the direction of the magnetic field, as shown in figure 1.2. T2 is the dephasing of the 
magnetic vector along the X-Y plane perpendicular to the course of the magnetic field.  
 
 
Figure 1.2) Schematic of both T1 and T2 relaxation mechanisms 
 
Systemic radio pulse sequences by changing Inversion recovery (IR) times and 
reputation time (TR) sequences generate  T1 and T2 maps. In most cases for T1, a range 
of IR times is picked, followed by a constant short TR on the vary from 1-5 seconds by 
keeping the TR short it limits the T2 interaction. For T2 measurements, a series of echo 
time(TE’s) are picked, followed by a long TR to show T2 interactions (3). Moreover, T1 
and T2 relaxation vary from the environment. For example, the cerebral spinal fluid 
will have a different T1 and T2 as opposed to the white or grey matter in the brain.  
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1.2 MRI contrast agents 
The development of contrast agents enhanced MRI resolution,  MRI contrast agents 
are widely used to enhance T1 or T2 times. Typically, gadolinium-based chelates are 
used  T1 contrast in clinics (4). The reason for this is that gadolinium consists of seven 
unpaired electrons in the outer shell of the metal ion giving rise to its unique magnetic 
properties. However, T2 typically uses iron oxide nanoparticles because they disrupt 
the magnetic field locally, causing inhomogeneities in the applied magnetic field flux 
and influencing T2 the relaxation mechanism(5). The T1 mechanism works with the 
interaction of the water protons with either the inner or outer sphere diameter 
forcing the relaxation of the water proton.  
 
 
 
 
 
 
 
 
Figure 1.3) Schematic of gadolinium chelate interaction with water(6). 
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Moreover, this chelation is not stationary; water molecules constantly move in and 
out of the inner and outer spheres, thus making the metal complex and proton 
interaction a dynamic process. In most common contrast agents, approximately 60% 
of the interaction is from the inner sphere, while the other 40% is contributed to the 
outer sphere(7). Either T1 or T2 contrast work in such a way to reduce T1 times or T2 
times, thus providing a contrast on T1 or T2 weighted images, respectively. 
Furthermore, the T1 and T2 can be calculated based on paramagnetic ion shown in 
equation 1. Where T1, obs is the observed relaxation time, T1,d is the relaxation time of 
background, R1 is the relaxation rate of contrast agent and finally [Gd] is the 
concentration of gadolinium   
(Equation 1.1) 
Equation 1.1  demonstrates that there is a linear relationship between the 
concentration of gadolinium and the observe relaxation time. Certain contrast agents 
already approved for clinical use have their values well defined, such as 
Gadovist(gadobutrol), which has a relxativity of both R1 and R2 of about 3.5 and 4.0, 
respectively. The relxativity of the contrast agent is not only dependent on the ligand 
of the metal ion, but also on the field strength that is applied. In general, the relxativity 
constant r1 decreases as field strength goes up(8, 9). Furthermore, this is 
predominantly because of the shift in the Larmor frequency, which is proportional to 
the magnetic field(4, 10, 11). More recently, since the success of Food drug 
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administration (FDA) approved contrast agents. Attention has turned to the use of 
contrast agents to target specific physiological events in the body, such as (Na+, K+, 
Mg2+, and Ca2+) (12).  
Table 1.1) Table of different relaxivities at different magnetic fields and different 
contrast agents. (13) 
 
 
 
 
1.3 Traumatic Brain Injury (TBI) and the physiological importance of calcium 
In recent years TBI has been a growing concern, with the majority TBI on sports-
related brain injuries. Yearly, about 2.5 million people in the United States are affected 
by TBI, along with 75 to 90 % of theses TBI injuries to be mild traumatic brain injuries  
(14). Moreover, there is not an adequate way to successfully diagnose or quantify the 
trauma the brain has received; instead, the treatment relies on the symptoms 
displayed by the subject. Testing mTBI is subjective and that this often causes miss 
diagnoses. Moreover, this leads to a  degree of uncertainty in the severity of the 
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trauma(15). Calcium plays an essential role in brain injury as well as other neurological 
events and diseases. Fluctuations of calcium levels in the brain after trauma causes 
elevated levels of calcium in the intercellular and lowering calcium levels in the 
extracellular region (16). The phenomenon(diffuse axel injury)  of the transport from 
calcium from the extracellular region of the brain to the intracellular region, where 
there is stretching and tearing of the axonal neurons(17). Furthermore, changes from 
calcium homeostasis can also have an impact on memory loss and other neurological 
dysfunctions(18). Studies indicate that current calcium levels existing in the 
extracellular region is in the range of about 0.1 mM to about 1.2 mM for what is 
considered proper calcium homeostasis (19). Moreover, the range of normal 
intracellular calcium levels is on the order of about 50 to 100 nM (20). Therefore, the 
level of calcium levels between both the intercellular region and extracellular region 
varies significantly, causing a high gradient between them. Approximately the 
extracellular region is about 10000 times more. Providing that at the time of injury, 
there is significant diffusion between the two regions, which in the end causes 
neurological cell death.  As calcium levels flood the intracellular region, the is a 
measurable drop in the extracellular region after trauma was induced (18). Thus, a 
contrast agent that can detect changes in calcium is essential for the nature of this 
phenomenon.  As mentioned above, calcium is vital for neurological events. As 
described in this study but also in other physiological areas as well, such as the heart. 
Ideally, it becomes the goal of this work to be able to generate contrast agents with 
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known material properties, quantification of certain psychological events. Helping to 
improve the lives of patients as well as further an understanding of the human body 
as well.     
1.4 Ion sensing contrast agents 
 
Ion sensing contrast agents are growing in development with the promise that they 
will help target specific ions that change during neurological events. A few of these 
novel contrast agents are still currently under construction. For example, a contrast 
agent that proved sensitive to zinc selectivity is presently being developed (21).  
 
 
 
 
 
 
 
 
 
Figure 1.4) Gadolinium coordinatized complex showing association and dissociation 
equilibrium with the presence of zinc ions. (21) 
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In which they have developed an organic molecule that was then further chelated to 
gadolinium. Figure 1.4 displays the structural conformation that occurs, then zinc is 
introduced into the system and thus changing the relaxivity of the contrast agent. 
Indicating that this complex then demonstrated a high affinity for Zn ions(21). 
 
 
Figure 1.5) Graph of equivalence of ZnCl2 as a function of relaxivity. (21) 
  
The plot of the R1 vs. ZnCl2 graph that demonstrates change indicating a dependence 
on zinc ions, as shown in figure 1.5. The graph shows that as the amount of ZnCl2, the 
relaxivity starts to decrease until it begins to plateau off at one equivalent of ZnCl2.The 
graph indicates a change in relaxivity until one molar ratio. Furthermore, other 
contrast agents in development show a dependence on calcium showed a calcium 
dependence using calmodulin and iron oxide nanoparticles(22). Thus, predominately 
  9 
making it a T2 contrast agent instead of T1. However, the calmodulin showed a 
dependence of around 500 μM(22). 
Furthermore, one of the more recent developments was the use and modification of 
1,2 bis(aminophenoxy)ethane-N, N, N′, N′-tetraacetic acid (BAPTA) as a way to 
synthesis a contrast agent that is effective and sensitive to calcium ions (23). As 
mentioned in the article, they successfully produced a manganese contrast agent that 
demonstrated a high affinity to calcium ions. They created the contrast agent by 
taking BAPTA and modifying it through nitration then a reduction to put a secondary 
amine successfully. Moreover, in figure 1.6, this gadolinium complex demonstrates its 
selectivity of Ca+2 over Mg2+ ions, which is one of the competing ions that is also a 
presence in the brain. The plot described in figure 1.6 displays relaxivity vs. a metal 
concentration (Mg+2or Ca+2). The two curves suggest that contrast dye is more 
efficient with the addition of calcium over magnesium, showing a change in relaxivity 
as the concentration of metal ions change. It is indicating about a 25% change in 
relaxivity at peak concentrations of metal ion levels. The contrast agent created could 
be used as a potential method to detect calcium in the brain.  
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This idea of ion growing contrast agents is growing, and it is one of the goals of this work 
to expand this idea of ions sensitive contrast agents to incorporate polymers instead of 
just small molecules.  
Figure 1.6) Graph of relaxivity of changes as a function of calcium and magnesium free ions  (21) 
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More interestingly, if we make a comparison of carboxylic acid ratios, we can try to 
understand what is happening with the carboxylic acid and calcium interaction.  In a 
theoretical scenario, it would take one free calcium ion per 2 carboxylic acid giving a 
max ratio of 0.5 [Ca]/[COOH]. When the ratio of [Ca]/[COOH] was examined in 
Angelovski et al., work his macromolecule seemed to demonstrate that the shortest 
T1 time being around 2 [Ca]/[polymer concentration] or about 1 [Ca]/[COOH] (24).   
Looking back at other literature examples such as the publication of the work of a 
Barandov et al. showed his macromolecules has a [Ca]/[COOH] of around 1 to 1.5 both 
demonstrating where the onset where his relaxivity curve starts to behave  
asymptotically (25). 
Figure 1.7) Figure showing Calcium interaction with BAPTA conjugated MRI 
contrast structure (21) 
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1.5 Fundamentals of chelation chemistry  
An understanding of chelation chemistry is necessary for the creation of these 
contrast agents. When examining chelates, there are three aspects the central metal 
atom, the chelating molecules, and the nature of the interaction between the 
chelating molecules and the central metal species. First, the metal ion forms complex 
bonds to its neighboring atoms allowing acceptance from an electron pair and 
allowing it to create a metal-ligand bond (26). This interaction with neighboring atoms 
attributes to the solubility of the metal ion and a reduction in toxicity from the metal 
ion(27). 
Figure 1.8) graph showing calcium interaction with BAPTA conjugated MRI contrast 
structure (22) 
 
  13 
Moreover, it is this interaction that allows contrast agents to become possible. For 
example, gadolinium in its free ion form is extremely toxic; however, in typical FDA 
approved contrast agents, the predominate chelator to this is some derivative of 
diethylenetriamine pentaacetic acid (DTPA). This chelation mechanism dramatically 
reduces the toxicity to the human body but taking up coronating sites that could 
interact with biological matter (28). Calcium chelators has been an interest in this 
work for the described in 1.3. One of the first calcium chelators is ethylene glycol-bis 
(β-aminoethyl ether)-N, N, N′, N′-tetraacetic acid (EGTA). However, it had some 
limitations, such as the kinetics of calcium bindings and the sensitivity to pH. To 
address some of the issues that EGTA had, a chemical company named Tsien 
developed BAPTA, which showed much high selectivity of magnesium, lower pH 
sensitivity, and higher rates of calcium association and dissociation (29). 
Most literature displayed shows four carboxylic acids from calcium-sensitive 
chelators. Perhaps this is likely due to a combination of more chelation elements and 
the structural conformation in space that can cause the orientation of compound to 
arrange itself around the metal species. In this way, the organics molecule acts as a 
change keeping the inorganic component at the center of the compound.    
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Figure 1.9) calcium interaction dye interaction with BAPTA dye 
 
Its the kinetics moderates the effectiveness of chelation. The faster the associates and 
dissociation of calcium, the more effective the chelator is. Essentially the higher the 
equilibrium constant in equation 2 means that the [calcium-ligand] concentration is 
higher, thus favoring metal-ligand complex coordination over the presence of free 
calcium. Equation 2  defines the chelation strength of the organic compound to the 
free calcium. Where K is the equilibrium constant and [calcium-ligand] is the 
concentration of calcium bound to the ligand, [free-calcium] is the Ca+2 ions in solution 
and [ligand] is the concentration of unbound ligands.   K = [calcium-ligand]/[free-calcium][ligand] (equation 1.2) 
Furthermore, this constant is greatly dependent on the pH of the system. This work 
focuses on gadolinium-based contrast agents because of the unique magnetic 
properties described in 1.2. Gadolinium chelates typically has a coordination number 
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of 9, such as Gd (III)Cl3 hexahydrate, gadobutrol, and gadoteridol. In gadobutrol and 
gadoteridol, there are eight coordinating ligands with an open available coordinating 
site for water interaction. This limits biological interaction while keeping the metal ion 
species soluble in polar media.   
1.6 Objectives 
It is the goal of this work to build off previous knowledge and construct an ion-
sensitive polymer MRI contrast agent using the knowledge of organic and polymer 
chemistry. Many of these polymeric reactions in the following chapters are either free 
radical polymerization or ionic reactions. With simple organic reactions such as SN2 
reactions or click reactions. As well as extensive characterization techniques. Such as 
nuclear magnetic resonance (NMR), Fourier transmission inferred spectroscopy 
(FTIR), and Inductively coupled plasma mass spectrometry (ICP-MS). NMR  after every 
step of synthesis with the addition of FTIR for certain steps. Then the final product 
gadolinium concentration was then tested using ICP-MS. As stated, before the primary 
goal of this project is to create a polymeric contrast agent that could potentially detect 
free calcium ions.  Also, this aims to discuss the effect of molecular weight on the 
relaxivity, T1, and T2 relaxation times of the polymeric contrast agent. To approach the 
problem, we first started with a simple approach, which described in chapter 2. 
Following a more advanced and controlled synthesis with the use of an already pre-
established calcium-sensing chelator (BAPTA -AM), which is then conjugated on to a 
polymer backbone, which described in detail in chapter 3. 
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CHAPTER 2  
Synthesis and characterization of Gd- 1,4,7,10-tetraazacyclododecane-1,4,7-tris (acetic 
acid) ethyl vinyl ether co maleic anhydride and analysis of MRI properties  
 
2.1 Introduction 
This chapter introduces one of the first approaches to create a polymeric MRI contrast 
agent. In this work, a simple method was adopted. It was thought that if it was possible 
to simplify the problem by constituting the polymeric contrast agent in two parts. A 
“chelating” component and a calcium responsive component. Moreover, the product that 
was needed to be synthesized had to a have at least readily accessible carboxylic acid 
components to bind to the free calcium in the system. As well as the ability to modify the 
polymer backbone as well. For this approach, we needed to select the monomers 
carefully. Furthermore, the polymer that we needed to create also had the constraint of 
being an alternating copolymer so that each carboxylic acid on the polymer backbone 
could coordinate with the corresponding gadolinium ion. Conveniently there is one well-
known polymer that can fit this category. An alternating copolymer between vinyl ethers 
and maleic anhydride is known to produce alternating copolymer (30, 31). For the 
monomer selection, 2-chloroethyl vinyl ether and maleic anhydride were chosen as the 
monomers. 2-chloroethyl vinyl ether is chosen because the vinyl chlorine group will 
provide a means of functionalization to cognate the chelating molecule. Once the 
molecule was chosen, the next decision is to pick a chelator component that we then 
could couple with the polymer. The chelator should be modeled after already approved 
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contrast agents such as Gadovist (gadobutrol) and ProHance (gadoteridol). This will allow 
us to compare it to a known reference. This chapter will discuss the synthesis of this 
polymeric contrast agent along with chemical, structural characterization, and its 
potential use as an MRI contrast agent. Ultimately a chemical structure of the 
corresponding polymer shown in figure 2.1 was chosen, and its possible interaction with 
calcium will take place. As calcium comes into proximity to the polymer backbone, the 
carboxylic acid will interact with calcium over coordinating with the gadolinium opening 
two free water interaction sites. Effectively making it a calcium-sensing polymeric 
contrast agent.  
 
N
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N
O O
O O OO
O
OO OO
Gd
n
N
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N
O O
O O OO
O
OO OO
Gd
n
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Figure 2.1) Theoretical interaction with calcium and polymeric contrast agent with the 
carboxylic acid group on the polymer backbone.  
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2.2 Synthesis of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane) 
(PDO3A) 
The synthesis of PDO3A was followed following Jagardish et al. As shown in figure 2.2. 
First, the cyclen(1,4,7,10-tetraazacyclododecane) was put into suspension with ten 
equivalents of sodium acetate with dimethylacetamide (DMA) under an inert N2 
atmosphere. Then three equivalents of t-butyl bromoacetate were dissolved in DMA. 
Afterward, the cyclen sodium acetate suspension was then cooled down to -20 °C in an 
acetone bath. Then the t-butyl bromoacetate solution was then added dropwise over 5 
minutes in which then the solution was then allowed to reach room temperature and 
continued stirring overnight. After 24 hours of stirring, water was then added into the 
solution until a clear solution was observed with any solids that were then was filtered 
out. 
  19 
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The product was then extracted from the solution by adding sodium bicarbonate until the 
crude product precipitated out of solution, which then was collected through vacuum 
filtration. The crude product was then dissolved in chloroform and washed 3x with water 
then dried with magnesium sulfate. The magnesium sulfate was then removed through 
filtration, and the organic solution was reduced under vacuum before precipitating out 
the cleaned product with the addition of diethyl ether. The product was then collected 
after filtration.  The product was then purified using silica gel chromatography with a 
mobile phase of 10:1 dichloromethane (DCM) and methanol solution. The solution was 
made by taking 500 ml of DCM and adding 50 ml of methanol. Silica gel was then added 
to a glass chromatography column. The amount of silica was based on 20x the mass of 
the crude product that was going to be purified. The first step was to put the silica into a 
slurry with the DCM-methanol solution. After then it was added to the column. The about 
1 column’s worth of DCM-methanol solution was then added with gently tapping the 
Figure 2.2) Trialkylation of t-butyl bromoacetate with cyclen for the formation of ,4,7-tris(tert-
butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane) hydro-bromine. 
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sides of the column to ensure compact packing. Afterward, just enough DCM-methanol 
solution mixture was added to dissolve the crude product. It was then pipetted into the 
column and allowed to dissipate through the silica. In which fractions were taken every 
10 to 15 ml. The fractions were checked using an iodine stain on a TLC plate to examine 
the product's elution time. After the fractions were collected, each was reduced under 
vacuum, and an NMR was taken of each fraction. After examining the NMR of each 
fraction, the purist fraction was collected and combined, which yielded the NMR spectra 
in figure 2.3. The peaks corresponding at 1.4 are significant of the t-butyl esters, while the 
peaks at 2.5 to 3.2 correlate to the cyclic ring, and the peaks 3.4 to 3.7 pertain to the 
protons on the t-butyl ester arm located next to the nitrogen. Given the proton NMR was 
able to identify each peak after purification is adequate proof that the reaction was 
successful. Furthermore, the NMR proton chemical shifts are also consistent with the 
literature values of the corresponding compound.   
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After the POD3A salt was correctly characterized with NMR, cleavage of the HBr group 
was then done using potassium bicarbonate in anhydrous acetonitrile with a temperature 
of 50°C as described in Xiao Y, Paudel R, Liu J, Ma C, Zhang Z, Zhou S (5). Afterward, the 
filtration of potassium bicarbonate was done; then, the organic solution was reduced 
under vacuum until dry. In order to remove any residual base, it was then dissolved in 
chloroform and washed with 3x times with water. After this, it was dried with magnesium 
sulfate then reduced under vacuum to afford PDO3A, as shown in figure 2.4.  The 
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Figure 2.3) NMR of 4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane) hydro-bromine. 
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difference between the cleaved PDO3A oil and the PDO3A salt is the reduction of the peak 
corresponding to 10ppm. As well as a change in physical properties, the PDO3A is just a 
clear, viscous oil, while the PDO3A is a white powder.  
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Figure 2.4) NMR of 4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane)  
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2.3 Synthesis of chloroethyl vinyl ether co maleic anhydride 
Cl
O
OO O
Cl
O
OO O
THF, 60°C
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An alternating copolymerization was done between 2-chloroethyl vinyl ether and maleic 
anhydride, as shown in figure 2.5.  The polymerization conducted as a free radical 
polymerization using 2,2′-Azobis(2-methylpropionitrile) (AIBN) as the radical initiator. 
This reaction was done in an inert environment where 1:1 molar equivalent of 2-
chloroethyl vinyl ether, maleic anhydride, and AIBN were added to a flask with the 
addition of tetrahydrofuran (THF). The reaction was then allowed to go for 2 hours. 
Afterward, the solution was then reduced under pressure. Then finally, the product was 
precipitated the diethyl ether and collected through vacuum filtration. An NMR and FTIR 
were then obtained and shown in figure 2.6 and figure 2.7 respectability. 
In this proton NMR, the total integration came out to be 1644 protons yielding a 
molecular weight of about 370 protons giving the approximate molecular weight of about 
11,000 g/mol and about 72 repeat units. The molecular weight is done by normalizing the 
NMR peak at 1.7 ppm as the AIBN starting unit and normalizing it to 12 protons because 
Figure 2.5) Scheme of radical polymerization of 2-chlorethylvinyl ether and 
maleic anhydride.  
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the termination mechanism is termination by disproportion for further structural 
conformation, and FTIR analysis was also done. The FTIR analysis was able to identify all 
functional groups in the polymer showing structural confirmation that the polymer was 
successfully synthesized.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6) NMR of 2-chloroethylvinyl ether-co-Maleic anhydride 
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2.4 Synthesis of modified 1,4,7,10-tetraazacyclododecane-1,4,7-tris(tert-
butoxycarbonylmethyl) ethyl vinyl ether co Maleic anhydride (CEVE-co-MA) 
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Figure 2.7) FTIR of 2-chloroethylvinyl ether-co-maleic 
anhydride 
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With the successful synthesis of both out polymer and out corresponding contrast 
agent, now a simple Sn2 reaction can be used to react the secondary amine on the 
PDO3A with the alkyl halide on the chloroethyl vinyl ether. For this, we react 1:1 molar 
equivalent of our alternating copolymer and the POD3A with TEA under reflux for 24 
hours. The solution was then precipitated in hexane and then purified using 7.5k 
molecular weight dialysis tubing, after which the following NMR spectra and FTIR 
spectra in figure 2.9 and figure 2.10 respectively. In this particular case, the following 
NMR showed us the approximate molecular weights of 12,725 g/mol and was 
determined similarly to how the method was done in section 2.3.  
 
 
 
 
 
 
 
Figure 2.8) Scheme of modified 1,4,7,10-
tetraazacyclododecane-1,4,7-tris(tert-butoxycarbonylmethyl) 
ethyl vinyl ether co maleic anhydride (CEVE-co-MA) 
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Figure 2.10) FTIR of 1,4,7,10-tetraazacyclododecane-1,4,7-
tris(tert-butoxycarbonylmethyl) ethyl vinyl ether 
Figure 2.9) NMR 1,4,7,10-tetraazacyclododecane-1,4,7-tris(tert-butoxycarbonylmethyl) 
ethyl vinyl ether co maleic anhydride (CEVE-co-MA) 
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2.5 Synthesis of modified Gd- 1,4,7,10-tetraazacyclododecane-1,4,7-tris (acetic acid) 
ethyl vinyl ether co maleic anhydride 
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The next step in our synthesis is a deprotection of the t-butyl esters groups into carboxylic 
acids. Deprotection was done using trifluoracetic acid (TFA) in excess to cleave the t-butyl 
ester into in carboxylic acid, after which gadolinium (III) chloride was added to for 
chelation forming the corresponding structure. The product was then further put through 
dialysis for two days, followed by lyophilization. The concentration of gadolinium in the 
sample was then characterized using ICP-MS with the isotope of gadolinium that was 
selected was Gd 157 as that was the most abundant isotope that provided no 
interference. In order to make sure that we get the correct concentration, a sample of the 
known amount was dissolved in a known amount of water in which it was pipetted into 
different scintillation vials at different volumes. The solutions were then put into an oven 
Figure 2.11) Scheme of Modified Gd- 1,4,7,10-tetraazacyclododecane-1,4,7-tris 
(acetic acid) ethyl vinyl ether co maleic anhydride 
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for 24 hours at 500 °C to decompose the organic polymer. After 24 hours, there was no 
observable matter in the glass scintillation vials. Then 15 ml of 2% w/v nitric was added 
to the vials, which was then placed into 15 ml centrifuge tubes. The samples were then 
taken to L.G. Rich Environmental Research Laboratory to have the samples analyzed 
through ICP-MS.  
 
2.6 MRI contrast properties of modified Gd- 1,4,7,10-tetraazacyclododecane-1,4,7-tris 
(acetic acid) ethyl vinyl ether co maleic anhydride 
The MRI analysis was done at the University of Alabama at Birmingham inside a 3  
Tesla siemens MRI in which the department of neurology obtained the scan. The 
experimental setup consisted of a bucket filled with water with our sample holder that 
was then placed in a headspace coil, as shown in figure 2.12.  In order to provide a better 
signal to noise ratio, the water in the bucket had 10 ml of ProHance to shorten the T1 and 
T2 of the background. The preparation of the samples was done by picking concentration 
of polymer was picked at certain concentrations as well as the calcium levels such that 
there were several chelate concentrations. These several concentrations were repeatedly 
made, only changing the calcium concentrations. Our initial studies involved calcium 
levels in the physiological range, such as 0 to 1.5 mM of calcium. While other studies show 
calcium levels at different ranges. Moreover, the [Ca]/[COOH] was also compared. 
Comparing the [Ca]/[COOH], in a way, gives some insight into how well this polymeric 
contrast agent interacts with calcium.  The sequencing for T1 and T2 was chosen through 
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the University of Alabama, Birmingham. The T1 sequences involved TRs at 4 seconds and 
predetermined IRs of 25, 50, 250, 500, 750, and 1200 milliseconds for the T1 
measurements. The corresponding T2 sequence uses 32 TEs and a TR of 4 seconds to help 
generate the T2 images. The T1 and T2 images were then used to create T1 and T2 maps 
using MATLAB software. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Briefly, the T1 and T2 images are imported into MATLAB in which then each pixel on each 
image undergoes an exponential curve fit, which is then exported out of MATLAB into a  
Figure 2.12) Image of experimental set up with the sample holder inside a head space coil a 
bucket filled with ProHance water surrounding the samples 
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corresponding dicom image called either a T1 or T2 map. An example of mapping is 
shown in figures 2.13 and 2.14, showing T1 and T2 mapping, respectively. Furthermore, 
in the image of the T1 mapping shows how the relaxation times of T1 were obtained 
through the exported dicom image. The software, RadiAnt, translates the pixel intensity 
of each voxel and gives out a corresponding average T1 time with max, min, and 
standard deviation over the area analyzed.  
 
 
 
Figure 2.13) Example of T1 mapping with how to get the corresponding T1 vales of each 
sample from the using RadiAnt as the software 
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Figure 2.14) Example of T2 mapping 
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Figure 2.15) T1 mapping of ProHance 
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Each T1 time was then recorded into an excel spreadsheet keeping note of the known  
Figure 2.16) T1 mapping of relxativity as a function of Gd concentration of 
ProHance with an R- squared value of 0.94 
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Figure 2.17) Graph of T1 vs calcium concentration for 0.25 mg/ml and 0.01666 mg/ml  
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polymer and calcium concentrations in each endorphin tube. However, before we 
conducted the experiments one of the first experiments that were done was the use of a 
known contrast agent for us to make comparisons and this is shown in figure 2.12, along 
with figure 2.16 which indicates the relaxivity generated from figure 2.15 
The selected contrast agent used was ProHance for comparison. The reason for 
this is because of its structural similarity to the chelate component of our polymeric 
contrast agent. The results indicate an R-squared value of 0.9485 with a linear slope of 
2.3643 L/mmol S in deionized water. This compares similarly to the reported values of 
ProHance of about 2.6 L/mmol S., Indicating that the MRI system acceptable to use for 
quantitative measurements. The same was also done with Gadvist (gadobutrol) which is 
another FDA approved contrast agent with known relaxation times and measurements  
The results were then plotted in several ways to help better understand the data. First, 
the T1 times were plotted as a function of calcium. Several plots are shown in graphs 
2.14 that showed the attempt to demonstrate the effect that calcium had on the 
system. Furthermore, an analysis was also compared with just DI water and samples of 
ProHance to indicate if the MRI scanner was working as intended. 
The sample of polymer concentration with corresponding values of 0.25 and 0.1666 
mg/ml shows relatively flat dependence on calcium until the concentration approaches 
one mM of calcium concentration. Then afterward, it is followed by a gradual increase 
after calcium levels reach high elevation. What is also observed what appeared to be is 
that as the concentration of polymer drops, the dip around 1mM becomes less and less 
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pronounced. However, there is still a gap in the calcium levels that we are examining, so 
further analysis is needed to exhibit this behavior.  For this, a new series ran to help fill 
the gap between the 0.6 mM and 0.8 mM. Unfortunately shows no indication of calcium 
response. We then looked at the results more closely we thus, we did construct plots of 
moles of Ca and moles of COOH as shown in graphs 2.18 for the 0.25 mg/ml series. In a 
theoretical scenario, it would take one free calcium ion per 2 carboxylic acid giving a max 
ratio of 0.5 [Ca]/[COOH] in an ideal case. When looking back previous literature on 
calcium-sensing ions such as Angelovski et al., work his macromolecule seemed to 
demonstrate a similar effect with the shortest T1 time being around 2 [Ca]/[polymer 
concentration] or about 1 [Ca]/[COOH] (21). Looking back at other literature, examples 
such as the publication of the work of a Barandov et al. showed his molecules have a 
[Ca]/[COOH] of around 1 to 1.5, both demonstrating where the onset where his relaxivity 
curve starts to behave asymptotically. Leading to suggesting  
evidence that a [Ca]/[COOH] ratio of around 1 to 1.6 indicate that once the  
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Figure 2.18) Graph of T1 vs [Ca]/[COOH] for 0.25 mg/ml chelate 
Figure 2.19) Graph of T1 vs constant calcium levels of 0.3333 and 1.6666 calcium 
concentration at 0 mM and 0.0833 mM of free calcium with R-squared 
values of 0.59 and 0.77 respectively   
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Macromolecules are saturated with calcium. The T1 values and relaxivity values do not 
change very much. It is shown that we didn’t exhibit the same dependency, as shown in 
graph 2.18.  Instead, a relativity flat line between T1 and Ca/COOH indicating that the is 
no observable behavior between T1 and the ratio between Ca/COOH. Potential reasons 
for this could be simply of structural repeat unit is simply not robust enough. To further 
elaborate previous literature uses BAPTA modified macromolecules, which provide two 
advantages. The first is that this molecule consists of four carboxylic acid groups readily 
available to bind the calcium as opposed to two.  
 
 
 
 
 
 
 
 
 
 
The next is that the backbone on our polymer contains a rather ridged carboxylic acid 
group. This means that the spatial conformation is limited to that of BAPTA and thus can 
lower binding affinity to free calcium ions. Other possibilities may suggest that since the 
Figure 2.20) Graph of T1 vs Constant calcium levels of 0 and 
0.08333 calcium concentration at 0 mM and 0.0833 mM 
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product was imaged in DI water, that it may not have a strong enough binding affinity to 
the calcium ions due to it being a close to neutral pH. This idea was, however, partially 
investigated. The pH of the solution was measured by both pH paper and pH probe, with 
only slight differences examined between the two. Overall, the pH of the solution was 
found to be about 7.3, which is a slightly basic environment. However, the samples were 
prepared at different concentrations at constant calcium levels. This is shown in figures 
2.20 at was shown here is the comparison of the R squared values and the linear 
equations. What is shown is that at low calcium levels, the equation that is referenced in 
chapter one, equation 1, proves to be true. However, if the calcium levels increase, the 
linearity in the curves starts to shift, showing no significant relationship between polymer 
concentration and the relaxation time. The results demonstrate that it shows not only T1 
change but that linear relationship between the concentration of gadolinium and the 
observed relaxation rates also change with varying levels of calcium concentration. In 
exaggeration, the linear constant [R1] shown in equation 1 to give an idea of how effective 
other contrast are no longer become a valid form of measurement for this contrast 
agent—indicating a possible way that calcium levels influence the system our polymer 
water interaction. We also wanted to examine how our polymer played a role in T2. As 
shown in figures 2.21 what was discovered was that the T2 curves showed similar results 
as T1 and that the only significant difference is that the relaxation times for T1 are great 
than the relaxation times for T2 meaning that T2 is always shorter than T1 and this is to be 
expected in all cases for MRI measurements.  The effect of T2 shorting can be attributed 
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to the fact that these are macromolecules that pose a heavy influence on T2. The 
mechanism is the slowing water protons rotation and diffusion processes. 
Moreover, this could also exemplify the effect of the hydrogen bonding between our 
polymer backbone and the free water protons, and this will also start to reduce T2 times. 
Only three considerations attribute to this effect. The first is the size of the particle. The 
second is the concentration, and lastly is the types of functional groups the polymer is 
composed of (32-34). However, for graph 2.23, there is not an obvious correlation 
between [Ca]/[COOH]. The reason could be due to the already short T2 times that are 
examined—thus making the results having a baseline effect.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.21) Graph of T2 vs Calcium Concentration for 0.25 mg/ml  
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2.7 Potential error in measurements 
As stated in this work, the T1 and T2 mappings were done through a MATLAB code. 
However, original mapping was done through Siemens using their software, and what was 
discovered was that each sample varied in T1 mappings by about 300ms. How the 
mapping was generated can attribute to this effect. A stated before IR times of 25, 50, 75, 
100, 250, 500, 750, 1000, and 1200 were conducted. However, the siemens software only 
takes two IR times for analysis, while our MATLAB code makes all the IR times to generate 
the mappings. We believe that since our map was constructed with more data points that 
it is more accurate to the actual T1 times as opposed to the siemens software. In terms of 
the T2 analysis, there was a little discrepancy with the mappings. This is likely because, 
just like the Siemens software, our MATLAB code takes into account all the echo times 
(TE), and thus the measurement is similar. Further investigation should be done to get the 
measurements more in accordance since this is for quantitative use. Nevertheless, the 
trending from the measured T1 and T2 are similar regardless of software and that these 
only affect just the measured T1 and T2 relaxation times. Thus the trend from reach graph 
represented in the chapter is still valid.   
2.8 Dynamic light scattering measurement 
Dynamic Light scattering measurements (DLS) were done on the samples varying in pH as 
well as calcium concentration to attempt to understand why no significant calcium 
response was observed. In previous literature Thomas Swift, Linda Swanson, a Mark 
Geoghegan, and Stephen Rimmer examined global to coil transitions based on the varying 
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effects of pH for polyacrylic acid(35). As shown in there study, the pH affects the 
molecular weight showing that a pH of a more acidic solution provided a more globular 
shape. In contrast, a higher pH produced a more linear chain conformation in their 
experiment. Furthermore, other studies also show that if pH changes with copolymers of 
N-isopropyl acrylamide, they also examine this coil to globular transition as pH was 
changed (36). Due to the nature of theses polymer to be able to carry charges species on 
their backbone. What was hypothesized is that our polymer showed aggregation. This 
could explain why there was shown no calcium response in the polymer. The exaggeration 
would not allow into the polymer backbone and thus limiting the calcium sensitivity of 
the polymer. For this, a light scattering experiment was conducted with the results 
located in appendix A.1 As shown in the results, the pH of the first polymer solution in DI 
showed a size of about 700 nm in diameter. Afterward, calcium chloride was added to 
adjust the calcium level in the sample to 0.5 mM, then 1mM, as shown the overall change 
in diameter, did not change very much, which suggests that calcium has little influence 
on the system. Then the pH was adjusted on the polymer system to see how that 
influenced the size measured by DLS. For this, the pH was adjusted to 1 and 14. What was 
shown in both ways that the DLS measurements showed a slight increase in particle size 
to 1200 nm in size. In all experiments, the measurements of the particle sizes proved to 
be quite large, perhaps indicating that there is aggregation forming from our particles, 
and that is why there is no calcium response as opposed to a globular conformation. Our 
size Also, the system may show a slight sensitivity to pH. Previous literature indicates that 
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DLS measurements for polyethylene glycol in the work of Nelson and Cosgrove 
demonstrated that PEG, a high molecular weight (1,000,000 g/mol), had a 10 nm 
hydrodynamic diameter(37). Furthermore, pertaining to the work of Melinda, Bodar, 
Hartmann, and Borbely, it was demonstrated that polyacrylic nanoparticles crossed linked 
gave a hydrodynamic diameter of 120nm (38). Similar work in Zhenyuan Qu, Fenglin Hu, 
Kaimin Chen, Zongqiang Duan, Hongchen Gu, Hong Xu conducted DLS measurements on 
their colloidal particles with a max measurement of 500nm (39). Since the DLS 
measurements around are samples, indicate at size on the order of 0.7 to 1.2 microns 
leads evidence to suggest that the polymer contrast agent is forming aggregation and thus 
is starting to represent measurements like a colloidal suspension as opposed to a dilute 
polymer solution.  Working through calculations for the dynamic size of the polymer using 
the equation Rh =K Mw(a) (3) where Rh is the hydrodynamic radius, K is a proportional 
constant, Mw is the molecular weight, and a can range from 0.5 to 3/5 depending on if 
the solvent is a good solvent or not. In our case, we will use an estimation based on the 
parameters of PEG, K = 0.145, and a = 0.571(40). In our case of this polymer, our 
hydrodynamic diameter is calculated to be 57.9 nm in hydrodynamic diameter. Moreover, 
an alternative way to calculate hydrodynamic diameter is us using the following equation 
(Rh= KT/(3 π (μ)D)) (4) Where K is the Boltzmann constant, T is the absolute temperature, 
μ is the viscosity and D is the translation diffusion coefficient. In our case, we will use 
Abohachem Laguecir  Serge Ulrich, Jerome Labille, Nicolas Fatin-Rouge, Serge Stoll, 
Jacques Buffle with polyacrylic acid to approximate the hydrodynamic diameter of our 
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polymer using a diffusion coefficient of 0.4(cm2/s*1x106)(41). After numerical calculation, 
the resulting hydrodynamic diameter is 1.2 nm in size. In both theoretical calculations, our 
measurement is much larger. Therefore, this provides some evidence to support that we 
do have aggregation. 
2.9 Conclusions 
Inconclusion, a successfully synthesized polymeric contrast agent, was made and 
characterized through FTIR and NMR along with each step that was characterized through 
NMR and FTIR.  The magnetic resonance imaging measurements show that there is no 
noticeable change in T1 times vs. calcium. Therefore, there is no noticeable change in R1 
rates versus calcium since in two a reciprocal of each other. However, the linear linearity 
of the T1 vs. chelate concentration does change as calcium levels are changed, giving this 
some potential to be still used. 
 Conclusively, results seem to indicate no changes in response to calcium other 
than the shift of linearity. The progress made here gives a good insight into why chapter 
three is so important for the future of ion sensing contrast agents. Further investigation 
is still needed to understand its lack of calcium responsivity. In chapter 3, the approaches 
made will help rectify some of the potential issues in chapter 2 as it takes more of a similar 
approach from literature.   
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CHAPTER 3 
Potential improvement of first design using controlled polymerization 
 
3.1 Introduction 
The results from chapter 2 indicate some potential for an ion sensing polymeric contrast 
agent. However, this initial design is not without its flaws. One of the first issues of the 
polymeric contrast shown in chapter 2 in the control of molecular weight since it is a free 
radical polymerization its disparities can vary and provide a wide range of molecular 
weights. This, in turn, could affect some of the MRI contrast properties that were also 
shown in chapter 2. Furthermore, common calcium chelating agents, as stated in chapter 
1, such as EDTA or BAPTA, have four carboxylic acid groups as opposed to our two 
carboxylic acids for the structure in chapter 2. Lastly, our polymer structure in chapter 2 
may not be selective towards just calcium ions but may be susceptible to other divalent 
ions such as magnesium. This chapter aims to examine an alternative polymeric contrast 
agent that aims to address some of the issues with the structure in chapter 2. For this 
approach, we wanted a controlled polymerization for finely controllable molecular weight 
as well as the use of a calcium dye (BAPTA), which has been proven to a great calcium 
chelator over other competing ions. For this, we have proposed two synthetic pathways 
that have the potential to lead to the final product, as shown in Figure 3.1. In each 
pathway involved is a controlled ionic polymerization. The first path was to construct a 
polymer then modify the polymer with two potential function groups for this reaction 
strategies were taken out of the work of Kim, Kweon, and Noh using BF3 (OEt)2 as the 
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initiator(42). The next one involves monomer synthesis then polymerizing at the end to 
produce our statistical copolymer. For this, we try modifying our epoxide ring with a ring-
opening using either a primary or secondary amine. Then later, a ring-closing reaction is 
done to reform the epoxide ring. The ring closed product could then be polymerized. This 
strategy constructed created from examples listed by Saddique et al. 2016 (43). 
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Figure 3.1) Image of repeat unit structure of new repeat unit using ether 
backbone that is both modified with BAPTA-AM and PDO3A.  
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3.2 Nitration and reduction of BAPTA 
The nitration of BAPTA was done by dissolving BAPTA in dimethyl sulfoxide then added 
1.5 equivalent of sulfuric acid with 1.5 equivalents of nitric acid over dropwise into the 
flask contain DMSO-BAPTA solution at room temperature. Then the reaction could stir 
overnight. The reaction scheme can be shown in figure 3.2. Afterward, the product in 
DMSO underwent lyophilization to remove DMSO, water, and acid from the solution. The 
carbon 13 NMR was done for structural identification. Then the nitrated BAPTA was 
dissolved in DMSO with the addition of Pd/C, which was then allowed to stir overnight in 
the open air. This process allowed for the reduction of the nitro group into a primary 
amine. The full reaction is as follows, the nitrated BAPTA (n-BAPTA) was added to a 50 ml 
flask was added to in with ethanol at room temperature. Then the Pd/C catalyst was 
added to the solution in 50 mg/mmol of substrate. The hydrogen gas was produced by 
dripping methanol into a suspension of sodium hydride and hexane and routed such that 
the hydrogen gas was able to bubble through the reaction solution. This reaction 
proceeded for 40 minutes before the reaction was stopped. The full reaction setup can 
be seen in the appendix A.2.     
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Figure 3.3) Theoretical reaction scheme starting with polymer synthesis  
 
Figure 3.2) Nitration of BAPTA then reduction using palladium on carbon to 
reduce nitro group into primary amine  
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In this pathway, we first take t-butyl alcohol and react it with BF3(OEt)2 with the addition 
of epichlorohydrin. The process is named a cationic polymerization reaction. The 
monomer and initiator ratio was picked, such that the target molecular weight is 10,000 
g/mol. This was done by using the following procedure described in Kim, Kweon, and 
Noh's work(42). Briefly, BF3(OEt)2 was added to a 250 ml flask, which was then put under 
vacuum. Then dry dichloromethane was then added to the flask. Afterward, the addition 
of epichlorohydrin was added dropwise to the flask at room temperature. The reaction 
was then allowed to react overnight, then was reduced under pressure and then 
precipitated in hexane. The product was then collected and analyzed. Using NMR, FTIR, 
and GPC. The NMR showed in figure 3.4 indicates the presence of an ether backbone and 
the presence of the end group. The FTIR shown in figure 3.5 had shown the indicated 
functional groups, while the GPC shown in figure 3.6 showed the molecular weight was 
low compared to polystyrene samples. The peak area of the lowest standard using the RI 
dictator is 436 in figure 3.6, with our sample peak being 11.1, as shown in figure 3.7.  This 
indicates that we have the formation of oligomers, which is evidence to suggest that the 
reaction was terminating early the potential issues for this could be the water in the flask 
at the time of the reaction or potential branching repeat units causing the reaction to 
terminate early. Further investigation is required; however, it does show early signs of 
success. 
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Figure 3.4) Proton NMR of PECH polymer 
 
Figure 3.5) FTIR of PECH showing formation of ether backbone and halogen 
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Figure 3.7) GPC elution of the sample showing 11.151 as g/mol as molecular weight by polystyrene 
standards 
Figure 3.6) Polystyrene GPC standards going from 500 to 99,000 g/mol 
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The next step of the process is to react the PDO3A as synthesized in chapter 2 with the 
chlorine in 0.5 molar equivalent using some base to help the nucleophilic attack then 
react the primary amine on the BAPTA with the other 0.5 molar chlorine of the 
epichlorohydrin. Then following similar procedures in chapter 2 for deprotection, react 
the polymer with trifluoracetic acid in 3 molar equivalent for 24 hours followed by 
evaporation of the acid in which an NMR and FTIR should then be taken. Finally, the last 
step should be to chelate with gadolinium (III) chloride hexahydrate for at least 24 
hours, followed by a purification process and characterization of ICP-MS. 
3.4 Pathway number 2 
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The second pathway involves synthesizing the monomer first before the polymerization 
the advantages of this is that the reaction can either be cationic or anionic polymerization. 
For this, nitration and reduction of the BAPTA is needed to be as shown in 3.1. Afterward, 
Figure 3.8) Second proposed pathway for synthesis 2.0 
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the addition of BF3(OEt)2 was added in 1:1:1 molar equivalent of the POD3A and the 
Epichlorohydrin under an inert atmosphere at 55 °C. The reaction was done in the 
following steps. First, the flask was flamed dried and purged with nitrogen, then BF3(OEt)2 
and Epibromohydrin was added to the flask with 10 ml of dichloromethane and was 
allowed to stir for 20 minutes at 55 °C. After this, a solution of PDO3A in 10 ml of 
dichloromethane was added dropwise into the flask and allowed to stir overnight. This 
reaction will force a ring-opening reaction, thus successfully modifying our PDO3A on to 
our substrate. Afterward, the reaction was then reduced under pressure and precipitated 
in hexane. As shown in the FTIR after purification, the presence of the carbonyl that is 
only presence on the PDO3A is still there as well as the presence of a hydroxyl group. This 
evidence suggests that there was a successful ring-opening reaction and that the EPI 
bromohydrin was successfully modified with the PDO3A chelating species. Followed after 
the FTIR and NMR analysis was conducted, as shown in figure 3.9, the presence of the t-
butyl esters protecting group, which also indicates that there was a successful ring-
opening reaction and that the secondary amine on the PDO3A was successfully converted 
into a tertiary amine.  
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Figure 3.9) NMR of Ring opened product of PDO3A with Epibromohydrin 
 
Figure 3.10) FTIR of ring opened product of PDO3A with Epibromohydrin.  
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In this case, both the NMR and the FTIR are in agreement with the ring-opening 
reaction.    
Afterward, the product was then treated with sodium hydride in 1.5 molar excess. The 
sodium hydride will deprotonate the oxygen and force the intramolecular ring-closing 
reaction. The reaction was done at 50°C overnight. In which the product was then 
reduced under pressure and precipitated in hexane. Then an FTIR was taken of the 
product as shown in figure 3.9 there an OH stretch peak at 3500 wave number after the 
ring-opening reaction and then after the reaction with sodium hydride as shown in 
figure 3.9 there is no longer any OH stretch at 3500 wave number indicating that the 
was removal of the hydroxyl group showing that the reaction was then ring closed.  
A similar reaction is done with the primary amine on the BAPTA and BF3(OEt)2 with the 
epichlorohydrin. Afterward, the two monomers would then be copolymerized using an 
anionic initiator of potassium bis trimethylsilyl amide would be used. It was chosen 
because of its ability to easily be disquisition NMR as well as its ability to be reduced to a 
primary amine after treatment with an acid such as trifluoroacetic acid. This provides it 
with more functionality for potential later uses. The potential reaction scheme is shown 
in figure 3.12 
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Figure 3.12) Proposed anionic reaction for pathway two done with the two-monomer synthesis  
 
 
 FTIR of ring closing product of PDO3A with 
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3.4 Discussion and future work 
The goal of chapter 3 was to provide two particular synthetic pathways for potential 
improvement from the theory derived in chapter 2. There are still some issues with each 
synthetic route to work out its optimal workup and reaction conditions. The most 
promising route so far has been the synthesis of the monomer before polymerization. 
This is likely since this reaction is not as water sensitive as the cationic polymerization. 
The FTIR before and after the ring-opening and ring-closing does show changes in the FTIR 
around 3500 wavenumbers showing the loss of alcohol peak. Showing evidence that the 
ring-closing reaction was successful. This potentially shows epoxide ring formation after 
reaction with sodium hydride. Also, the same reaction ring opening followed by a ring-
closing reaction for after the nitration of the BAPTA-AM calcium chelator accurately 
synthesized and characterized with FTIR and NMR.   
Moreover, for future work, the polymerization of the two monomers should also 
be done with reaction conditions yet to be determined likely plans for to perform the 
reaction at -20 °C  followed by a workup and then an NMR and FTIR of the final product. 
As well the deprotection of the t-butyl groups on the polymer backbone and chelation 
with gadolinium (III) chloride hexahydrate further needs to be done, as well as purification 
and characterization of how much gadolinium should be analyzed by ICP-MS.  Finally, an 
analysis of its MRI properties needs to be conducted.  The study should be like how the 
polymeric contrast agent in chapter 2 should be done.  
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CHAPTER 4  
Conclusion and future work 
 
4.1 Conclusion  
  All synthetic work has been successful and characterized by FTIR and NMR 
spectroscopy. However, the application for the designed structure in chapter 2 did not 
work as intended. This is still a step in understanding how ion sensing chelates. From the 
data, it was concluded that a more robust polymeric contrast agent is needed to probe 
the free calcium ions. Which still leads to needing development in chapter 3. The new and 
proposed polymeric contrast agent is more in line with how current literature approaches 
this problem.  
The fundamental difference is that in chapter 2 the polymer synthesized consists 
of 2 carboxylic acids groups per repeat unit and is a quite rigid structure and the polymer 
designed mentioned in chapter three shows great promise as it also addresses these 
issues as well in the sense that it builds off already established calcium-sensing chelates 
more specifically BAPTA-AM. As mentioned, the cationic reaction in chapter 3 caused 
early termination likely due to the presence in the water. The ring-opening approach, 
then the ring-closing approach, provides a better synthetic route. This is because 
purification of the monomers can be conducted after the reaction then the 
polymerization can be done afterward. This would seem to provide better control over 
the synthesis and properties.  
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In conclusion, the polymeric structure in the chapter was successfully synthesized and 
characterized as well as the MRI properties examined as well as its effects of calcium on 
the polymeric structure. The ring-opening and ring-closing rection in chapter 3 was 
successfully carried out and characterized through FTIR and NMR.   
 
4.2 Future work 
In chapter 2 of this work, more information needs to be gathered on the non-
chelating water-soluble polymer in order to further help establish the meaning of the 
DLS results. Such as synthesizing and producing polyacrylic acid or polymethacrylic acid 
and copolymerization of polyacrylic acid with maleic anhydride or copolymerizing 
polymethacrylic acid with maleic anhydride. Also, a more in-depth scattering study 
could be done such as small-angle x-ray scattering or static light scattering 
  Work that currently needs to be done is the predominantly from chapter 3. Such 
polymerization of the ring closed EPI-PDO3A hydrin, as mentioned in and the EPIBAPTA-
hydrin, as mentioned in 3.2.  Future work also includes successful polymerization into a 
statistical copolymer afterward, the deprotection of the protecting groups of the needs 
to be done using trifluoracetic acid followed by a workup and characterization using FTIR 
and NMR. Afterward, a Chelation using gadolinium (III) chloride hexahydrate allowing at 
least 24 hours for reaction in methanol. Finally, the characterization of the amount of 
gadolinium can be done using ICP-MS after dialysis to remove any remaining ions. 
Afterward, samples should be made in the physiological range of calcium between 0 and 
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1.5 mM with polymeric contrast ranges based on the results of the ICP-MS. Then finally, 
the same analysis done for chapter 2 can be done for chapter 3. Moreover, depending on 
the resulting test should be implemented to see how biocompatible the material is.  
 In terms of analysis development of MATLAB software was done to produce the 
T1 and T2 mappings of the samples. Still, when compared to the MRI software for mapping, 
it results varied in measurements meaning that there is an error in the measurement, and 
this needs to be further studied to reconcile the difference, and perhaps a better 
approach for how the mapping is made using MATLAB should also be further investigated.  
 Furthermore, in addition to the use of chapter 3 the can further built on using 
other calcium chelators such as FURA-2 as another potential modifier to our functional 
polymeric chelator due to its high affinity and ability to fluoresce under UV light gives an 
idea for a new candidate that could be both MRI sensitive and multifunctional (44).   
 Moreover, what hasn’t yet been answer adequately in the thesis is the effect of 
molecular weight on both relaxation and ion sensitivity. After the work proposed in 
chapter three is done, it is recommended that several molecular weights be produced 
followed by an MRI study and then compare the relaxation times the relxativity constant 
of each contrast agent to see if there is a difference.  
 Furthermore, the biocompatibility of either product of chapter 2 or chapter 3 has 
yet to be tested. Thus a series of tests need to be done to see how compatible they are 
with biological systems, as well as studying the diffusion rates of the polymer throughout 
the body.   
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APPENDICES 
Appendix A.1- DLS size analysis in diameter of each sample 
modification 
  Appendix A.2- Set up of reaction for hydrogenation of n-BAPTA with hydrogen 
production reaction on the right and bubbling into reaction vessel on the left 
69 
